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1 Introduction 
 
Throughout the past decades a remarkable increase in guideline development has 
occurred due to professional, public and political request for evidence-based practice 
(Craig & Smyth 2007: 237). Past guidelines were based on tradition, individual opinion 
or contemporary practice, but currently guidelines are expected to be founded on 
evidence. While a substantial collection of evaluated clinical guidelines has been 
developed in medicine, there is a growing interest and demand for evidence based 
clinical guidelines in nursing. (Craig & Smyth 2007: 238.) 
 
In this final project the term guideline will be used to refer to literature titled best 
practices, guidelines, policy, protocol, recommendations, standard of practice or 
instructions. 
 
Antimicrobial medications are used to manage infections caused by different microbes. 
Bacteria, fungi, protozoa and viruses are examples of microbes, which are organisms 
of microscopic or submicroscopic size, invisible to the naked eye. Antimicrobial drugs 
are called by different terms, each with slightly different meaning. Pharmacological 
classification groups the antimicrobial agents according to their action mechanism. For 
example bacteriocidal agents kill bacteria, while bacteriostatic drugs manage to slow or 
inhibit the growth of bacteria. (Adams & Urban 2013: 829; Medical Dictionary for the 
Health Professions and Nursing 2012.) 
 
Elimination or control of an invading micro-organism while not damaging healthy body 
cells is the foundation of effective antimicrobial therapy. Early forms of antimicrobial 
therapy involved the use of chemicals such as mercury or carbolic acid that had shown 
to kill bacteria. However, these as well as other bacteriocidal chemicals would often 
cause equal amounts of damage in the patient’s healthy body cells as they did to the 
microbe causing infection. Contemporary antimicrobial medications selectively target 
features present on invading microbes but not on human cells, thus reducing harm to 
the patient. (Wilson 2006: 87.) 
 
Antibacterial, antiviral, antiretroviral, antifungal, antiparasitic, antihelminthic and 
antiprotozoal medications are all anti-infective drugs that fight microbial infection 
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(Aschenbrenner & Vennable 2009: 746). For clarity purposes the term antimicrobial 
medication will be used in this final project to refer to any kind of anti-infective drug. 
 
There is a worldwide concern over the increasing emergence of antimicrobial 
resistance (Barajas, López-Alcalde, Roqué i Figuls, Solá, & Bonfill Cosp 2013: 5). The 
rapid development of drug-resistant strains of micro-organisms is enabled by their fast 
cell division, which includes mutations that can lead to developing an advantage 
against anti-microbial agents that previously have been effective against the micro-
organism. The development of resistant strains has been shown to be promoted by 
widespread utilization of antimicrobials, but can be hindered by means of infection 
prevention and control, accurate diagnosis and therapy as well as rational use of 
antimicrobials. (Adams & Urban 2013: 831-833.) 
 
Resistant strains of micro-organisms can develop due to inappropriate use of 
antimicrobials (Sanchez-Manuel, Lozano-Garciá, & Seco-Gil 2012: 2). It is crucial for 
nurses to have a comprehensive understanding and knowledge of appropriate 
antimicrobial medication administration, infection control policies and antimicrobial 
resistance patterns. This will aid in prevention and controlling of further antimicrobial 
resistance. This will help maintain the usefulness of currently used antimicrobial 
medications. (Guervil & Chau, 2013: 345.) 
 
This final project focuses on antimicrobial medication administration through peripheral 
intravenous access. Intravenous administration is irreversible and with a variety of risks 
such as local irritation, phlebitis, infiltration, extravasation, infection, fluid overload, 
embolism, thrombosis, anaphylaxis and even death (Aschenbrenner & Vennable 2009: 
34; Scales 2008: 4; Intravenous Nursing New Zealand Incorporated Society 2012: 56-
62). 
 
2 Background 
 
2.1 Nursing guidelines 
 
The term clinical guideline can be defined as a “systematically developed statement to 
assist practitioner decisions about appropriate health care for specific circumstances” 
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(Field & Lohr 1990 cited in Craig & Smyth 2007: 238). They are used to practice 
evidence based nursing and for reduction of incorrect practice (Craig & Smyth 2007: 
238). The aim of evidence-based practice is the development of efficient interventions 
to achieve the best possible quality and quantity of patients’ life (Craig & Smyth 2007: 
269).  
 
Guidelines ought to comply with approved standards and include documentation of 
adherence to the standards. Nursing has been involved in multiprofessional teams 
developing clinical guidelines.The quality of clinical guidelines in nursing requires 
improvement, because instead of research evidence they are widely based on 
professional opinion. Comprehensive systematic review provides a foundation for the 
development of useful guidelines that will integrate research into nursing practice. 
(Newhouse 2010: 57-59.) 
 
Support and criticism of the use of guidelines are based on varying views of the issues 
they focus on and of the benefits or disadvantages they provide. Guidelines improve 
safe practice and consistency of care, and hence patients are more likely to receive 
correct treatment. However, they ought to be used with discretion and interpretation is 
required individually with each patient. The application of guidelines has been objected 
due to the fact that individual clinical decision-making on care and treatment options 
can be limited. (Craig & Smyth 2007: 259-260.) 
 
Craig and Smyth (2007: 239) state that local guidelines have fewer resources but are 
more likely to be applied in clinical nursing practice, despite often not having adequate 
skills and resources in the development. Clinical guidelines are an excellent way to 
integrate evidence to clinical nursing practice (Craig & Smyth 2007: 261). 
 
2.2 Peripheral intravenous antimicrobial medication administration 
 
Intravenous administration passes medication and fluids to the blood circulation. This 
route conveys the medication directly to all tissues of the body with 100% bioavailabil-
ity, compared to other routes that include the factor of absorption that affects the level 
of drug in bloodstream. This route is preferable when quick onset of action is required. 
(Adams & Urban 2013:37; Lavery & Ingram 2008:44.) 
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As nurses are responsible for delivering intravenous therapy, they need to comprehend 
the indications why their patients have vascular access devices and that they should be 
removed when no longer required. Intravenous cannulae are a direct route for microbial 
contamination in the bloodstream and a significant factor in causes of morbidity and 
mortality. Hence good nursing pracitice is vital in intravenous therapy and in infection 
control. (Scales 2008: 12.) 
 
Despite its many advantages, intravenous administration is irreversible and medication 
is irretrievable once given (Aschenbrenner & Vennable 2009: 34). The intravenous 
route of administration carries a variety of risks such as local irritation, phlebitis, infiltra-
tion, extravasation, infection, fluid overload, embolism, thrombosis, anaphylaxis and 
even death (Scales 2008: 4; Intravenous Nursing New Zealand Incorporated Society 
2012: 56-62). Medications ought to be administered according to prescription from a 
licenced practitioner. Aseptic technique as well as standard safety measures need to 
be observed whilst administering intravenous medications and solutions. (Dougherty et 
al. 2010: 45.) 
 
The peripheral intravenous route of medication administration should only be chosen 
when other routes are not applicable, and when rapid response is required among oth-
ers. Nurses are responsible for the safe and accurate administration of medicines, 
hence they need to understand the indications and contraindications for intravenous 
administration and the care and management of the peripheral access device. 
(Downie, Mackenzie, Williams & Hind 2010: 64; Scales 2008: 4.) 
 
Three main forms of intravenous administration are large-volume infusion, intermittent 
infusion and bolus administration. In large-volume infusion the medication is mixed to a 
large volume of infusion fluid such as normal saline. Medications that need to be dilut-
ed or infused slowly can be administered intermittently with a flow control device or by 
gravity. A bolus injection of medication means administering a single dose of medica-
tion into the bloodstream without dilution or a background infusion. (Adams & Urban 
2013: 37; Scales 2008: 8.) 
 
There are three main types of intravenous access devices; peripheral venous cathe-
ters, midline catheters and central venous access devices (Taylor, Lillis, LeMone, & 
Lynn 2010: 1448). The veins of the ventral and dorsal upper extremities, for example 
the metacarpal, cephalic, basilic, and median veins, are to be considered for peripheral 
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intravenous access. Lateral and ventral surfaces of the wrists, compromised veins 
(bruised, infiltrated, phlebitic, sclerosed, or corded) and veins in the lower extremities 
should be avoided because of potential tissue and nerve damage, thrombophlebitis 
and ulceration, respectively. (Intravenous Nursing New Zealand Incorporated Society 
2012: 32.) 
 
Aseptic technique in intravenous medication administration includes hand-washing 
before and after clinical procedures and both before and after using gloves. Gloves do 
not protect the nurse from needlestick injury, instead they are worn for protective 
purposes against contamination by for  example blood, bodily fluids, micro-organisms 
and also toxic substances. The nurse should wear a disposable apron for preventing 
the contamination of clothing. Face masks and caps are not necessary in infusion 
procedures, but are used in situations where there is a risk of splashing bodily fluids or 
some other hazardous substances into the nurse’s face, mouth or eyes. Finally, the 
use of protective equipment prevents contamination among staff and patients. 
(Dougherty et al. 2010: 10-12.) 
 
It is important for the nurse to decontaminate the tops of ampoules and vials, the 
additive ports of infusion bags and the catheter hubs by rubbing an antimicrobial 
solution with friction. The solution should be left to dry before access or use. This is 
done in order to prevent the entry of micro-organisms to blood circulation. (Dougherty 
et al. 2010: 12,22.) 
 
Ideally, preparations that are in a form ready for administration should be used. If these 
are not available, they should be prepared in an appropriate location and all hazards 
should be minimized. Medications that are hazardous to the health must be 
reconstituted in a laminar flow cabinet, where air flow is led in a way that prevents con-
tamination by airborne micro-organisms. Guidelines provided by the manufacturer must 
be followed for reconstitution of specific medications. The reconstitution and 
administration of medications must be ascertained according to their chemical, physical 
and therapeutic properties. In these circumstances a registered pharmacist should be 
consulted about the compatibilty of medications. (Dougherty et al. 2010: 11-12; Medical 
Dictionary for the Health Professions and Nursing 2012.) 
 
The medication should be labeled immediately after preparation to ensure patient 
safety. The label should state the name, strength and volume of the medication and 
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diluent, the route of administration, the name of the receiving patient, expiry date and 
the name of the nurse who prepared the medication (Dougherty et al. 2010: 12).  
 
Storage of medication should follow the guidelines provided by the manufacturer to 
ensure the validity of the expiry date. Health care professionals should verify the expiry 
date by checking the attached labels before initiating the medicine administration or 
using of  equipment and products. Medication or solutions that have been added into 
an infusion bag should be disposed of or infused within 24 hours. (Dougherty et al. 
2010: 12,45.) 
 
Healthcare workers are at risk of being infected with HIV, hepatitis B, hepatitis C and 
other blood borne diseases due to accidental puncture with a needle infected with 
blood. Broken or bent sharps must not be resheathed but disposed of in impenetrable, 
puncture resistant and tamper proof containers. Containers for hazardous material and 
wastes should be used to dispose of the sharps accordingly. Sharps containers should 
be carried by their handles and placed in a secure place away from the public prior to 
ultimate disposal as medical waste by incineration or other high temperature system. 
(Dougherty et al. 2010: 13; Downie et al. 2010: 71.) 
 
The nurse’s responsibility is to ensure that medications and delivery systems are com-
patible. The preparation should be checked by another person before infusion. The 
vascular access device needs to be decontaminated with antimicrobial solution and 
flushed sufficiently between administering different medications. (Dougherty et al. 
2010: 12, 22, 45.) 
 
After the administration of intravenous antimicrobial medication the nurse should doc-
ument in the patient’s records the antimicrobial drug administered, including the dose, 
rate, time and the route of administration. The assessment and monitoring of the pa-
tient’s symptoms and vital signs as well as their response to therapy, including adverse 
reactions and complications, should be documented accordingly. (Dougherty et al. 
2010: 16-18.) 
 
Administration sets need to be replaced immediately after suspected or actual contam-
ination occurs, or the integrity of the system is compromised. Sets used for continuous 
infusion must be replaced after 72 hours of previous change, and those used for inter-
mittent infusion every 24 hours. Aseptic technique and the manufacturer’s instructions 
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ought to be followed when handling administration sets, add-on devices and electronic 
flow-control equipment. (Dougherty et al. 2010: 20, 23; Scales 2008: 10.)  
 
 
Antimicrobial medication that is not suitable for the patient or is administered incorrectly 
can have undesired effects with dire consequences for the patient (Wanzer, Goeckner, 
& Hicks, 2011: 341). Therefore, the nurse needs to ensure safe and consistent, 
evidence-based practice by using for example the 9 rights of intravenous therapy: 
confirm the identity of the patient, the prescription and appropriateness of the drug, the 
suitability of the intravenous administration route, the correct dosage, dilution and 
infusion rate, the correct timing, the monitoring of the patient and the documentation. 
(Lavery 2011: 33-34.)  
 
3 Purpose, aim and study question 
 
The purpose of this final project is to describe the existing guidelines of peripheral 
intravenous antimicrobial medication administration, with the ultimate goal to improve 
the use of guidelines in nursing practice. The study question is as follows: what are the 
existing guidelines for administration of peripheral intravenous antimicrobial 
medication? 
 
4 Method  
 
4.1 Literature review  
 
A literature review is an extensive research and analysis of literature about a specific 
subject. The aim of a literature review is to produce a summary of the existing litera-
ture, where relevant articles are searched and analysed to form a comprehensive de-
scription of the topic. Allowing single pieces of research to be seen within a wider con-
text of related literature, these reviews are generally more useful to health care practi-
tioners. Due to the increasing importance of evidence based practice in nursing, litera-
ture reviews have become more relevant to nursing practice. (Aveyard 2011: 2; 5-6; 
22.) 
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 A systematic review is the most accurate form of literature review. A detailed docu-
mentation of the study process is important to demonstrate the literature search, analy-
sis and synthesis. (Aveyard 2011: 13-14; 19-20.) Undertaking a systematic approach in 
the review of literature is essential to ensure all relevant data available is collected to 
the review. Carrying out such a review includes following a focused searching strategy 
to “identify, critically appraise and synthetize relevant studies”. This involves continuing 
the search until exhaustion, all in order to ensure no relevant literature remains omitted. 
(Aveyard 2011: 14.) 
 
The reviewers establish criteria of inclusion and exclusion that are used to critique the 
identified literature. To ensure that only papers of high quality and relevance to the 
study question are selected for review, search results that fail to meet the inclusion 
criteria are excluded. (Aveyard 2011: 14.) In this final project the principles of literature 
review are applied. 
 
4.2 Data collection and selection 
 
According to Parahoo (2014:126) “every effort to locate all relevant studies must be 
made”. Thus several initial article searches were carried out during autumn 2014 to 
identify relevant search terms and to explore relevant databases. These searches 
provided insight and knowledge for background information which helped the authors 
to initiate the development of relevant search terms and. The principles of a literature 
review were applied to identify guidelines for peripheral intravenous antimicrobial 
medication administration. The data collection consisted of searches in the PubMed, 
Medline, Cinahl and Cochrane online databases for publications between January 
2004 and December 2014. The search terms “peripheral intravenous” “antimicrobial”, 
“intravenous antimicrobial”, “intravenous administration”, “intravenous therapy”, 
“infusion therapy”, “IV”, “guidelines” and “nurs*” were used.  
 
Articles were selected from the search results in a systematic manner and the initial 
selection was based on the title. In total 1343 search results were identified. The 
inclusion criteria (Table 1) were applied to the title and thereafter 350 articles were 
chosen for further assessment. The authors applied the same criteria in the 
assessment of abstracts. However, potentially relevant articles without abstracts were 
chosen for full review. After selecting and reading 140 relevant articles entirely, 12 
articles were chosen for content analysis. Of the 12 articles five were about the use of 
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antimicrobials in treatment of infection, three were about the prophylactic use of 
antimicrobials in surgery, one recommendation was for prophylaxis and treatment of 
HIV-1 infection in pregnancy and one was about antimicrobial use in donor care. 
Sources included five pharmaceutical, five medical and only two nursing journals. The 
data collection and selection is summarised in Table 2 (Appendix 1) and the chosen 
literature is presented in Table 3 (Appendix 2).  
 
Table 1. Inclusion and exclusion criteria in database searches 
Inclusion criteria 
 
Exclusion criteria 
Focus on peripheral intravenous administra-
tion and antimicrobial medication 
Focus on central intravenous administration 
and other topics irrelevant to study question 
Full text published in English Full text not available 
Published in a scientific journal or as an evi-
dence-based guideline 
Lack of relevant guidelines, recommenda-
tions or instructions 
Published within January 2004 and 2014 published before 2004 
 
4.3 Data analysis 
 
Like all literature, also guidelines need to be reviewed in detail to assess their quality in 
terms of validity, reliability. Unclear or absent documentation of evidence base is a limi-
tation in the reliability of literature, and should be discussed even if the content is valid 
to the review. (Aveyard 2011: 118.)  
 
Content analysis is an objective and systematic method that can be used for analysing 
documents with the aim of producing a comprehensive and extensive description of 
concepts identified within the topic. It can be used to analyse both qualitative and quan-
titative data in a deductive or inductive manner. (Elo & Kyngäs 2008: 108-109.) 
 
The principles of an inductive content analysis were applied as recommended by Lauri 
and Kyngäs (2005, cited in Elo & Kyngäs 2008: 109). In inductive content analysis 
words, phrases or themes derived from the data are systematically grouped into cate-
gories, allowing particular items to be analysed and combined into general statements. 
The reason of forming categories is to organize knowledge to enhance understanding 
of the topic. (Elo & Kyngäs 2008: 108-111.) 
 
According to Elo and Kyngäs (2008: 111) abstraction can be defined as a means of 
formulating a comprehensive description of the study topic by generating categories. 
10 
 
These categories are named with words that characterize their content. Subcategories 
with similar content are joined together into categories, which are further grouped into 
main categories. The purpose is to continue this to a reasonable extent. 
 
The authors analyzed the chosen articles together. Parts of text, such as short sen-
tences, tables or entire chapters that were relevant to the study question were high-
lighted. The highlighted quotations were further analyzed and the authors identified 
guidelines, recommendations or instructions concerning several elements of peripheral 
intravenous antimicrobial administration. The highlighted sections in the articles were 
coded according to the identified elements. Similar elements were combined and even-
tually five distinct elements of the peripheral intravenous administration process were 
established. These were further grouped into two categories. The content analysis is 
summarized in table 4 (Appendix 3). 
 
5 Findings 
 
During the content analysis, guidelines, recommendations or instructions answering the 
study question were identified. In different articles there was inconsistency in where the 
guidelines were located because the structure of the articles differed in various 
sources. Five key elements of intravenous administration of antimicrobials emerged. 
Different guidelines, recommendations and instructions regarding the dosage, prepara-
tion and storage of intravenous solutions as well as the duration and timing of infusion 
of antimicrobial medication were found. These were further grouped into the categories 
named preparation and infusion of intravenous antimicrobial medications. 
 
5.1 Preparation of intravenous antimicrobial solution 
 
The authors identified guidelines for preparation of antimicrobial drugs. These instruct-
ed in the dosing, reconstitution and storage of intravenous antimicrobial solutions.  
 
5.1.1 Dosage of antimicrobial medication 
 
All articles chosen for review had guidelines or recommendations regarding dosage. 
Seven articles, all of which were pharmaceutical reviews, discussed specific antimicro-
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bial agents (Anderson & Perry 2008; Frampton 2013; Hylands 2008; Kasbekar 2006; 
Keady & Thacker 2005; Mariat et al. 2006; Schriever et al. 2005). Dosage adjustment 
for patients with hepatic impairment, such as no need for adjustment or need for re-
duced drug dosage, was discussed in four guidelines (Frampton 2013: 1084; Hylands 
2008: 262; Kasbekar 2006: 1241; Schriever et al. 2005: 1154). Six articles recom-
mended no adjustments or drug dosage reductions according to creatinine clearance 
values for patients with renal impairment or undergoing dialysis (Anderson & Perry 
2008: 557; Frampton 2013:1084; Hylands 2008: 262; Kasbekar 2006:1241; Powner & 
Allison 2007: 272; Schriever et al. 2005: 1154). One guideline gave specific dosages of 
antimicrobials in pediatric patients (Bratzler et al. 2013: 197) and one provided dosage 
information for delivering mothers and their infants (Navér et al. 2011: 415). 
 
5.1.2 Reconstitution of solution 
 
Two articles (Hylands 2008:261; Schriever et al. 2005: 1154) had guidelines for the 
reconstitution of intravenous solutions. Both articles instructed the choice of diluent to 
use in reconstitution of the intravenous antimicrobial solution. Hylands (2008: 261) also 
described the reconstitution process in more detail, including the volume of diluent to 
use. 
 
5.1.3 Storage of intravenous antimicrobial solutions 
 
One article (Schriever et al. 2005:1154) had a guideline about storage. The guideline 
stated how long the intravenous solution will be stable in both room temperature and 
refrigerated. 
 
5.2 Intravenous infusion of antimicrobial medication 
 
The guidelines for infusion instructed or recommended the timing, or administration 
interval, and duration of intravenous antimicrobial medications either related to general 
use or to specific treatments and prophylaxis. 
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5.2.1 Timing of infusion 
 
All the 12 articles chosen for review had guidelines about the timing of antimicrobial 
infusion. Five guidelines had specific timing recommendations regarding prolonged 
administration intervals according to creatinine clearance values for patients with renal 
impairment ( Anderson & Perry 2008: 557; Frampton 2013: 1084; Kasbekar 2006: 
1241; Powner & Allison 2007: 272; Schriever et al. 2005: 1154). Navér et al. (2011: 
415) recommended timing of infusion for women during delivery and for the infant. 
 
Three guidelines regarding patients undergoing dialysis had specific timing instructions 
for intravenous antimicrobial medications. Two of them recommended prolonged inter-
vals of dosing (Anderson & Perry 2008:557; Schriever et al 2005: 1154). The latter 
guideline instructed to infuse antimicrobials after haemodialysis. A third study dis-
cussed patients receiving continuous infusion of antimicrobial medication while under-
going continuous venovenous hemodiafiltration (Mariat et al. 2006).  
 
5.2.2 Duration of infusion 
 
Nine articles (Anderson & Perry 2008: 557; Frampton 2013: 1084; Hylands 2008: 261; 
Kasbekar 2006: 1241; Keady & Thacker 2005: 371; Mariat et al. 2006: 1; Navér et al. 
2011: 415; Schriever 2005: 1154; Wolf et al. 2008: 1384) had recommendations re-
garding the duration of infusion of which three had recommendations of infusion rate 
(Keady & Thacker 2005; Mariat et al. 2006; Navér et al. 2011). Mariat et al. (2006) rec-
ommend an infusion rate for a continuous infusion and Navér et al. (2011) recom-
mended the duration of infusion for women during delivery and for the new born infant. 
 
6 Discussion 
 
The purpose of this final project was to describe the guidelines for peripheral intrave-
nous administration of antimicrobial medication. A review of literature obtained from the 
Medline, CINAHL, Cochrane and PubMed databases was carried out, and only scarce 
and fragmented guidelines relevant to nursing practice were identified. Only two rele-
vant articles from a nursing publication were chosen, the remaining ten being from 
medical and pharmaceutical literature. 
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In this literature review no comprehensive guidelines relevant to nursing practice in the 
administration of intravenous antimicrobial medication were identified. Out of 1343 
search results yielded from four databases, only 12 were considered relevant to the 
study question. The identified guidelines instructed what to do in specific situations, but 
no description of how the intervention ought to be carried out could be found. In the 
absence of evidence-based, comprehensive guidelines of how to perform nursing 
interventions, nursing practice is based on tradition which may cause errors or 
inconsistency in the adminstration of intravenous medication to occur. Patient safety 
will be compromised in these situations.   
 
Majority of the excluded articles were discarded due to lack of clear guidelines or 
recommendations. Several review articles merely stated their results, such as one 
antimicrobial agent being superior to another, but no recommendations or instructions 
could be identified within the article. In addition, most excluded articles did not provide 
guidelines or they did not even discuss the administration process of intravenous 
antimicrobial medications, but rather focused on pharmacological properties or medical 
outcomes. 
 
During the last phase of the article selection process the authors deemed articles titled 
as research protocols to be consistently unfit for the review, because they focused on 
describing a research plan without providing recommendations nor guidelines. Lastly, 
many articles did not initially specify the route of administration to be intravenous, 
instead the route of administration was described only in sections other than the title or 
the abstract. Due to this factor, articles that were initially deemed relevant, were 
discarded only in the final selection stage when the full articles were assessed. 
 
Guidelines for clinical nursing interventions like intravenous medication administration 
need to guide how to perform the intervention. No single guideline instructed how the 
comprehensive process of intravenous antimicrobial medication administration should 
be carried out, and therefore they cannot be used as guidelines in the clinical nursing 
procedures of preparation and infusion of medication. While the findings contained 
information relevant to nursing, they cannot be used in clinical practice. 
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7 Ethics and validity  
 
The authors strived to carry out this final project according to ethical principles which 
are endorsed by the research community in Finland (Finnish Advisory Board on 
Research Integrity 2012). To ensure validity of a literature review the authors need to 
appraise several aspects. To our best knowledge, the aim of the final project is clearly 
defined, the background literature is connected to the data reviewed, and the chosen 
research method is relevant to the research question. 
 
The study method used in this literature review are accurate. Ethically sustainable 
methods that comply with scientific criteria have been used to perform the data search, 
selection, analysis and reporting the study findings. Both authors read all articles 
chosen for the review and each phase of the analysis process was carried out together. 
The findings were presented as accurately as possible without adding any subjective 
content. The work of other researchers has been taken into consideration, credited and 
cited accordingly. This means no findings were fabricated, plagiarised or falsified 
during this final project. 
 
The documentation of the data collection and analysis should be clear and transparent 
to the reader and the findings objectively presented. (Maltby, Williams, McGarry & Day 
2010: 252-258). The authors have strived to achieve this by using methodological liter-
ature (Aveyard 2011, Parahoo 2014,  Elo & Kyngäs 2008 and Finnish Advisory Board 
on Research Integrity 2012) as reference throughout the final project to ensure the va-
lidity of the study. In any problematic situations the aforementioned professional litera-
ture was utilised to solve methodological issues and thus the authors have to their best 
knowledge applied the principles of literature review and inductive content analysis in a 
correct and accurate manner. In addition, guidance from the highly qualified senior lec-
turer instructors has been utilised regularly throughout the final project. 
 
No ethical issues arose during this literature review, and any disagreements were re-
solved through discussion. However, possible limitations to the validity of this study 
include the authors’ lack of experience in reviewing and critically appraising profes-
sional literature. Moreover, the data was collected from only academic publications in a 
limited time frame, thus many guidelines that are used in clinical practice might have 
been omitted if they have not been published in academic journals, or if they have not 
been published within the ten-year time frame applied for this review. 
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8 Conclusion 
 
During this final project, the authors found that there is an abundant variety of high 
quality, evidence based medical guidelines. The scarcity and poor quality of nursing 
guidelines was evident. This finding emphasizes the crucial need for clinical nursing 
perspective in future guideline development. Nurses are competent professionals who 
should be encouraged to find, understand and, most importantly, document the clinical 
evidence behind their practices, even the ones based on good traditions. Documenting 
best practices should be encouraged and supported by both management and 
practicing nurses. 
 
Nurses need to actively get their voices heard and take part in producing policies, 
recommendations and clinical guidelines on local and national levels. When the 
viewpoints of all members of the multiprofessional health care team are included, they 
will be able to provide the highest quality, evidence-based care to their patients. 
Inconsistency, errors and adverse events can be reduced when all health care 
professionals adhere to the same guidelines, which will also promote teamwork in 
health care and  be beneficial to patients. 
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Database Search terms Limitations Hits Chosen by 
title 
Chosen 
by ab-
stract 
Chosen 
by full 
text 
CINAHL 
Peripheral intravenous AND 
antimicrobial medications 
AND best practices 
 
2004-2014 
English 
99 10 5 2 
Antimicrobial AND intrave-
nous administration AND 
guidelines 
 
2004-2014 
English 
3 2 1 1 
Antimicrobial AND intrave-
nous administration AND 
guidelines AND nurs* 
 
2004-2014 
English 
0 0 0 0 
Intravenous Antimicrobial 
AND intravenous admin-
istration AND nurs* 
 
2004-2014 
English 
1 0 0 0 
Intravenous Antimicrobial 
AND best practice AND 
nurs* 
2004-2014 
English 
153 30 8 4 
Intravenous antimicrobial 
AND recommended guide-
lines AND nurs* 
 
2004-2014 
English 
131 41 15 5 
Medline 
Peripheral intravenous AND 
antimicrobial medications 
AND best practices 
2004-2014 
English 
5 star rele-
vance 
 
0 0 0 0 
Antimicrobial AND intrave-
nous administration AND 
guidelines 
2004-2014 
English 
5 star rele-
vance 
 
2 0 0 0 
Antimicrobial AND intrave-
nous administration AND 
guidelines AND nurs* 
2004-2014 
English 
5 star rele-
vance 
 
0 0 0 0 
Intravenous Antimicrobial 
AND intravenous admin-
istration AND nurs* 
2004-2014 
English 
5 star rele-
vance 
 
0 0 0 0 
Intravenous Antimicrobial 
AND best practice AND 
nurs* 
2004-2014 
English 
5 star rele-
vance 
 
0 0 0 0 
Intravenous antimicrobial 
AND recommended guide-
lines AND nurs* 
2004-2014 
English 
5 star rele-
vance 
0 0 0 0 
Table 2. Data collection and selection 
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Cochrane 
Peripheral intravenous AND 
antimicrobial medications 
AND best practices 
 
2004-2014 
English 
32 12 4 0 
Antimicrobial AND intrave-
nous administration AND 
guidelines 
 
2004-2014 
English 
118 59 23 0 
Antimicrobial AND intrave-
nous administration AND 
guidelines AND nurs* 
 
2004-2014 
English 
52 18 11 0 
Intravenous Antimicrobial 
AND intravenous admin-
istration AND nurs* 
 
2004-2014 
English 
68 25 15 0 
Intravenous Antimicrobial 
AND best practice AND 
nurs* 
 
2004-2014 
English 
67 23 13 0 
Intravenous antimicrobial 
AND recommended guide-
lines AND nurs* 
 
2004-2014 
English 
49 18 11 0 
PubMed 
Peripheral intravenous AND 
antimicrobial medications 
AND best practices 
 
2004-2014 
English 
0 0 0 0 
Antimicrobial AND intrave-
nous administration AND 
guidelines 
2004-2014 
English 
292 82 24 2 
Antimicrobial AND intrave-
nous administration AND 
guidelines AND nurs* 
 
2004-2014 
English 
15 2 1 0 
Intravenous Antimicrobial 
AND intravenous admin-
istration AND nurs* 
 
2004-2014 
English 
123 27 9 2 
Intravenous antimicrobial 
AND best practice AND 
nurs* 
 
2004-2014 
English 
15 2 0 0 
Intravenous antimicrobial 
AND recommended guide-
lines AND nurs* 
2004-2014 
English 
6 0 0 0 
Total 
1343 350 140 12 
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Table 3. Analysed articles (n=12) 
Author(s), 
year, country 
where the 
study was 
conducted 
Purpose Partici-
pants 
(sample 
size) 
Data collec-
tion and 
analysis 
Main results Remarks 
Anderson, V. 
& Perry, C.: 
Levofloxacin: 
A Review of 
its Use as a 
High-Dose, 
Short-Course 
Treatment for 
Bacterial In-
fection, 2008, 
USA 
To examine 
the pharma-
cology of 
levofloxacin 
and focus 
specifically on 
the clinical 
profile of the 
high-dose, 
short-course 
regimen in 
the treatment 
of adults with 
community-
acquired 
pneumonia, 
acute bacteri-
al sinusitis, 
complicated 
urinary tract 
infection and 
acute pyelo-
nephritis 
Not clear-
ly stated 
Database 
search 
(MEDLINE, 
EMBASE), 
manual 
search. 
Analysis not 
discussed. 
Levofloxacin is 
a valuable 
antimicrobial 
agent that has 
activity against 
a wide range 
of bacterial 
pathogens; 
however, it’s 
use should be 
considered 
carefully so 
that the poten-
tial for re-
sistance selec-
tion can be 
minimized and 
it’s usefulness 
in severe in-
fections and 
against a 
range of peni-
cillin- and 
macrolide 
resistant path-
ogens can be 
maintained. 
 
Instructions in 
a pharmaceu-
tical review 
Bratzler et al.: 
Clinical prac-
tice guidelines 
for antimicro-
bial prophy-
laxis in sur-
gery, 2013, 
USA 
An update to 
a previously 
published 
American 
Society of 
Health Sys-
tem Pharma-
cists Thera-
peutic Guide-
lines on Anti-
microbial 
Prophylaxis in 
Surgery 
(1999), as 
well as guide-
lines from 
Infectious 
Disease So-
ciety of Amer-
ica and Sur-
gical Infection 
Society. 
 
Not clear-
ly stated 
Not clearly 
stated 
Key updates 
on pre-
operative dose 
timing, selec-
tion and dos-
ing, duration of 
prophylaxis 
and common 
principles. 
 
 
Clinical prac-
tice guidelines 
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Frampton, J.: 
Ceftaroline 
Fosamil: A 
Review of its 
Use in the 
Treatment of 
Complicated 
Skin and Soft 
Tissue Infec-
tions and 
Community-
acquired 
Pneumonia, 
2013, Switzer-
land  
To review 
antibacterial 
activity, 
pharmacody-
namic and 
pharmacoki-
netic proper-
ties, efficacy 
and tolerabil-
ity of ceftaro-
line fosamil. 
Not clear-
ly stated 
Database 
search 
(MEDLINE; 
EMBASE), 
manual 
search. 
Analysis not 
discussed. 
Ceftaroline, 
the active me-
tabolite of 
ceftaroline 
fosamil is an 
advanced-
generation, 
parenteral 
cephalosporin 
with a broad 
spectrum of 
microbiological 
coverage that 
includes path-
ogens com-
monly impli-
cated in skin 
and soft tissue 
infections and 
community 
acquired 
pneumonia. 
 
Recommen-
dations in a 
pharmaceuti-
cal review 
Hylands, J: 
Tigecycline: A 
new antibiotic, 
2008, UK 
To review the 
clinical effica-
cy, side effect 
profile, dosing 
and admin-
istration of 
tigecycline 
and discuss-
es the warn-
ings and pre-
cautions as-
sociated with 
the use of the 
drug. 
Not stated Not stated Tigecycline 
may be used 
for complicat-
ed intra-
abdominal and 
complicated 
skin and soft 
tissue infec-
tions. It is also 
likely to find a 
role in the 
treatment of 
infections 
caused by 
multi-resistant 
organisms. 
 
Instructions in 
a pharmaceu-
tical review in 
a nursing 
journal 
Kasbekar, N: 
Tigecycline: A 
new glycylcy-
cline antimi-
crobial agent, 
2006, USA 
To review the 
pharmacolo-
gy, spectrum 
of activity, 
pharmacoki-
netics, clinical 
efficacy, ad-
verse events, 
dosage and 
administra-
tion, drug 
interactions 
and place in 
therapy of 
tigecycline. 
Not stated Not stated Tigecycline is 
a valuable 
treatment op-
tion for man-
agement of 
multi-drug 
resistant or-
ganisms when 
first line thera-
py fails. It pro-
vides a new 
option for pen-
icillin-allergic 
patients or 
patients with 
intolerance to 
other antimi-
crobial agents. 
Recommen-
dations in a 
pharmaceuti-
cal review 
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Keady, S. & 
Thacker, M.: 
Voriconazole 
in the treat-
ment of inva-
sive fungal 
infections, 
2005, UK 
To review the 
clinical effica-
cy, side effect 
profile, dosing 
and admin-
istration 
schedule of 
voriconazole. 
 
Not stated 
 
 
Not stated Voriconazole 
is an effective 
treatment op-
tion in the 
management 
of fungal infec-
tions. 
Recommen-
dations in a 
pharmaceuti-
cal review in a 
nursing jour-
nal 
Mariat, C. et 
al.: Continu-
ous infusion 
of ceftazidime 
in critically ill 
patients un-
dergoing con-
tinuous veno-
venous he-
modia-
filtration: 
pharmacoki-
netic evalua-
tion and dose 
recommenda-
tion, 2005 
To analyze 
the pharma-
cokinetics of 
ceftazidime 
administered 
by continuous 
infusion in 
critically ill 
patient during 
continuous 
venovenous 
hemodiafiltra-
tion in order 
to identify the 
optimal dose 
in this setting. 
 
7 patients Blood sam-
ples were 
collected 
simultane-
ously for 
pharmacoki-
netic and 
statistical 
analysis 
A dosing regi-
men of 3g/day 
ceftazidime by 
continuous 
infusion, fol-
lowing a 2 g 
loading dose, 
results in se-
rum concen-
tration more 
than 4 times 
the minimum 
inhibitory con-
centration for 
all susceptible 
pathogens. 
Recommen-
dations in a 
medical article 
Navér et al.: 
Prophylaxis 
and treatment 
of HIV-1 infec-
tion in preg-
nancy: Swe-
dish Recom-
mendations 
2010, 2011, 
Sweden 
Availability of 
new antiretro-
viral drugs, 
updated gen-
eral treatment 
guidelines 
and increas-
ing 
knowledge of 
the im-
portance of 
drug re-
sistance have 
necessitated 
updating the 
previous 
(2007) rec-
ommenda-
tions. 
 
Not stated 
 
 
Not clearly 
stated 
Several up-
dates in differ-
ent recom-
mendations 
Prophylaxis 
and treatment 
recommenda-
tions 
Powner, David 
J. & Allison, 
Teresa A.: 
Bacterial in-
fection during 
adult donor 
care, 2007, 
USA 
To review 
issues of 
bacterial in-
fection in 
adult organ 
donor care. 
 
 
 
 
 
 Appropriate 
treatment of 
documented or 
suspected 
bacterial infec-
tions in the 
donor may be 
important to 
the recipient. 
Therefore, the 
organ pro-
curement co-
Recommen-
dations in a 
medical article 
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ordinator is 
challenged to 
continue 
hospital-based 
efforts to pre-
vent infection, 
to diligently 
review all prior 
culture data, 
and to search 
for clinical and 
laboratory 
signs of new 
infection. 
 
Schriever, C. 
et al.: Dap-
tomycin: A 
novel cyclic 
lipopeptide 
anti-microbial, 
2005, USA 
To review the 
development, 
activity, 
pharmacoki-
netics, phar-
macodynam-
ics, clinical 
efficacy, ad-
verse effects, 
dosage and 
administration 
of daptomy-
cin. 
Not stated Not stated Daptomycin is 
bactericidal 
against a 
range of gram-
positive bacte-
ria, including 
many multiple-
drug-resistant 
isolates. It has 
only minimal 
activity against 
anaerobic 
bacteria and 
no activity 
against gram-
negative bac-
teria. Dap-
tomycin offers 
an option in 
the treatment 
of complicate 
skin and skin 
structure infec-
tions. 
 
Instructions in 
a pharmaceu-
tical review 
Trampuz, An-
drej; Zimmerli, 
Werner: Anti-
microbial 
agents in or-
thopedic sur-
gery, 2006, 
Switzerland 
To review the 
pathogenesis, 
prophylaxis 
and treatment 
of orthopae-
dic device-
associated 
infections. 
Not stated 
 
 
Not stated Perioperative 
prophylaxis 
should be 
administered 
between 60 
and 30 
minutes before 
incision. The 
duration of 
prophylaxis 
should not 
exceed 1 day. 
 
Recommen-
dations in a 
medical re-
view article 
Wolf, J. et al.: 
Best Practice 
Policy State-
ment on Uro-
logic Surgery 
To formulate 
recommenda-
tion on the 
use of antimi-
crobial 
Not stated Database 
search 
(MEDLINE), 
expert opin-
ion, analysis 
Antimicrobial 
prophylaxis is 
recommender 
only when the 
potential bene-
Best practice 
policy state-
ment 
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Antimicrobial 
Prophylaxis, 
2008, USA 
prophylaxis 
during uro-
logic surgery. 
not dis-
cussed. 
fit outweighs 
the risks and 
anticipated 
costs. Prophy-
laxis should 
begin within 60 
minutes of 
surgical inci-
sion and gen-
erally should 
be discontin-
ued within 24 
hours. 
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Table 4. Data Analysis 
Source Anderson & Perry 2008 Bratzler et al. 2013 Frampton 2013 
Dosage IV Levofloxacin 
Renal impairment 
Peritoneal dialysis 
Commonly used antimicrobials in adults  
Commonly used antimicrobials in pediat-
rics 
Ceftaroline fosamil in adults 
Moderate and severe renal impairment 
Hepatic impairment 
Preparation    
Storage    
Timing of 
infusion 
IV Levofloxacin 
Renal impairment 
Peritoneal dialysis 
Commonly used antimicrobials in adults 
 
Ceftaroline fosamil in adults 
Moderate and severe renal impairment 
 
Duration of 
infusion 
IV Levofloxacin  Ceftaroline fosamil in adults 
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Source Hylands 2008 Kasbekar 2006 Keady & Thacker 2005 
Dosage IV tigecycline in general 
severe hepatic impairment 
IV Tigecycline in general 
Tigecycline in renal impairment 
Hepatic impairment: mild and severe 
IV Voriconazole for all patients 
Preparation Reconstitution with NaCl 0.9 % or dex-
trose 5% 
  
Storage    
Timing of 
infusion 
IV tigecycline in general 
 
IV Tigecycline in general 
Tigecycline in renal impairment 
 
IV Voriconazole for all patients  
Duration of 
infusion 
IV tigecycline in general IV Tigecycline in general 
 
IV Voriconazole for all patients 
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Source Mariat et al. 2005 Navér et al. 2011 Powner & Allison 2007 
Dosage IV ceftazidime For the woman in vaginal delivery  at < 34 
weeks 
For the infant born at > 34 weeks if oral 
not possible 
For infant < 34 weeks 
Recommendations for empiric intravenous 
antibiotics for different conditions 
Recommendations for intravenous antibi-
otic dosing during renal failure 
Preparation    
Storage    
Timing of 
infusion 
IV ceftazidime continuous infusion For the woman in vaginal delivery  at < 34 
weeks 
For the woman in cesarean delivery 
For the infant born at > 34 weeks if oral 
not possible 
For infant < 34 weeks 
Recommendations for empiric intravenous 
antibiotics for different conditions 
Recommendations for intravenous antibi-
otic dosing during renal failure 
Duration of 
infusion 
IV ceftazidime continuous infusion For the woman in vaginal delivery  at < 34 
weeks 
For the woman in cesarean delivery 
For the infant born at > 34 weeks if oral 
not possible 
For infant < 34 weeks 
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Source Schriever et al. 2005 Trampuz & Zimmerli 2006 Wolf et al. 2008 
Dosage IV daptomycin in general 
Renal dysfunction 
Hepatic dysfunction 
For arthroplasty and internal fixation of 
closed fractures in centres with low infec-
tion rates 
Grade I and II open fractures in centres 
with unknown or high infection rates 
Internal fixation of grade III open fractures 
Different antimicrobial agents for peripro-
cedure use 
Antimicrobial prophylaxis for orthopedic 
patients 
Preparation Reconstitution with NaCl 0.9%   
Storage Refrigeration up to 48 h 
Room temperature up to 12 h 
  
Timing of 
infusion 
IV daptomycin in general 
Renal dysfunction 
After hemodialysis 
Timing for perioperative prophylaxis be-
fore incision  
Timing when tourniquet is used  
For arthroplasty and internal fixation of 
closed fractures in centres with low infec-
tion rates 
Grade I and II open fractures in centres 
with unknown or high infection rates 
Internal fixation of grade III open fractures 
Different antimicrobial agents for peripro-
cedure use 
Antimicrobial prophylaxis for orthopedic 
patients 
 
Duration of 
infusion 
IV daptomycin in general For arthroplasty and internal fixation of 
closed fractures in centres with low infec-
tion rates 
Grade I and II open fractures in centres 
with unknown or high infection rates 
Internal fixation of grade III open fractures 
Antimicrobial prophylaxis for orthopedic 
patients 
 
